Cobas Influenza A/B Nucleic Acid Test for Use on the Cobas Liat System
K-Number: K191729 · 2019-07-24
Device Summary
Frequently Asked Questions
What is the Cobas Influenza A/B Nucleic Acid Test for Use on the Cobas Liat System?
Cobas Influenza A/B Nucleic Acid Test for Use on the Cobas Liat System is a medical device that received FDA 510(k) clearance on 2019-07-24. It is manufactured by Roche Molecular Systems, Inc.. The 510(k) number is K191729.
When was Cobas Influenza A/B Nucleic Acid Test for Use on the Cobas Liat System approved by the FDA?
Cobas Influenza A/B Nucleic Acid Test for Use on the Cobas Liat System received FDA 510(k) clearance on 2019-07-24, under approval number K191729.
What company makes Cobas Influenza A/B Nucleic Acid Test for Use on the Cobas Liat System?
Cobas Influenza A/B Nucleic Acid Test for Use on the Cobas Liat System is manufactured by Roche Molecular Systems, Inc..
What is the FDA product code for Cobas Influenza A/B Nucleic Acid Test for Use on the Cobas Liat System?
The FDA product code for Cobas Influenza A/B Nucleic Acid Test for Use on the Cobas Liat System is OCC.
Related Clinical Trials
Other Devices by Roche Molecular Systems, Inc.
Related Devices (Code: OCC)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.